First Quadrant’s CONMED CNMD Stock Holding History

First Quadrant’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,213	Closed	-$78K	–	724
2018 Q4	$78K	Buy	+1,213	New	+$83K	0.01%	675
2013 Q4	–	Sell	-4,700	Closed	-$160K	–	797
2013 Q3	$160K	Buy	+4,700	New	+$153K	﹤0.01%	565

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Quadrant's CNMD Position: Q1 2019 in Review

First Quadrant sold out of CONMED (CNMD) in Q1 2019, closing a stake of 1,213 shares — an estimated $78K sold.

First Quadrant first reported a position in CNMD in Q3 2013 and held it in 2 quarters. The position peaked at $160K in Q3 2013. 226 funds tracked by Wall St. Rank hold CNMD as of Q1 2019.

First Quadrant reported no remaining CONMED position as of Q1 2019 after selling out during the quarter.
First Quadrant sold 1,213 CONMED shares in Q1 2019, an estimated $78K.
First Quadrant first reported a position in CONMED in Q3 2013 and held it in 2 quarters.
First Quadrant's CONMED position peaked at $160K in Q3 2013.
226 funds tracked by Wall St. Rank held CONMED as of Q1 2019.

Based on First Quadrant's 13F filing for Q1 2019, filed 24 Apr 2019.